Appointment

July 31, 2026 To National Stock Exchange of India Limited The Secretary Exchange Plaza, C-1, Block G, BSE Limited Bandra Kurla Complex, PJ Towers, Dalal Street Bandra (E) Mumbai: 400 001 Mumbai – 400 051 Company Scrip Code: 500411 Company Scrip Code: THERMAX EQ Sub: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Dear Sir / Madam, In reference to our earlier intimation dated May 7, 2026 regarding outcome of Board meeting, we wish to inform you that the shareholders of the Company, at their 45th Annual General Meeting (AGM), held on Thursday, July 30, 2026, have approved the re-appointment of Dr. Ravi Shankar Gopinath (DIN: 00803847) as Non-Executive Independent Director of the Company for a second term of five consecutive years from November 10, 2026 till November 9, 2031 (both days inclusive). The voting results of the 45th Annual General Meeting of the Company have been filed with the Stock Exchanges on July 31, 2026. The requisite details as required by SEBI Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026, regarding the same are enclosed herewith as Annexure “A”. This is for your information and records. You are requested to kindly take note of the same. Thanking you, Yours faithfully, For THERMAX LIMITED, Sangeet Hunjan Company Secretary & Compliance Officer Membership No: A23218 Encl: as above Annexure A Sr. No. Disclosure Requirements Brief Particulars 1. Reason for change viz. The shareholders of the Company at their 45th Annual General appointment, re-appointment, Meeting (AGM), held on Thursday, July 30, 2026, have resignation, removal, death or approved the re-appointment of Dr. Ravi Shankar Gopinath otherwise (DIN: 00803847) as Non-Executive Independent Director of the Company for a second term of five consecutive years from November 10, 2026 till November 9, 2031 (both days inclusive). 2. Date of appointment/re- Dr. Ravi Shankar Gopinath (DIN: 00803847) has been re- appointment/cessation (as appointed as Non-Executive Independent Director of the applicable) & term of Company for a second term of five consecutive years effective appointment/re-appointment from November 10, 2026 till November 9, 2031 (both days inclusive) 3. Brief profile (in case of Dr. Ravi Shankar Gopinath is the Chief Strategy Officer at appointment); AVEVA plc, a FTSE listed software company. He joined AVEVA in 2018 through the merger of Schneider Electric Software with AVEVA. Prior to the merger, he was the Executive Vice President of Schneider Electric Software. He joined Schneider Electric in 2014 following the acquisition of Invensys plc by Schneider Electric, where he was President of Invensys Software. He started his career as a Research Scientist in Tata Consultancy Services in 1994 and eventually led the Global Engineering business and the Manufacturing practice for the company. He left TCS in 2006 and joined Geometric Ltd. as the MD & CEO. He held that role from 2006 to 2009, when he joined Invensys. Dr. Gopinath holds a Ph.D. in Chemical Engineering from Rensselaer Polytechnic Institute, New York and a M. Tech in Chemical Engineering from the Indian Institute of Technology Bombay. 4. Disclosure of relationships Dr. Ravi Shankar Gopinath is not related to any other Director between directors (in case of on the Board of the Company. appointment of a director) 5. Non-debarment Dr. Ravi Shankar Gopinath is not debarred from holding the office of Director by virtue of any order of the Securities and Exchange Board of India (SEBI) or any other authority.